Symposium:
40. Infectious Issues in the Pre-Transplant Patient
Friday, October 21, 2011: 10:45 AM-12:15 PM
Room: 104ABC

Learning Objectives:

At the conclusion of this session, participants will have knowledge of selected pathogens in the patient undergoing transplantation and will be able to:

  • explain the risk for complications post-transplant
  • describe the diagnostic evaluation and monitoring post-transplant
  • summarize approaches to prevention and treatment post-transplant

Target Audience: Physicians who care for transplant patients, Scientists, Researchers, Pharmacists, Microbiologists, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Fellows-in-Training, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Moderators:  Ajit Limaye, MD, University of Washington and Emily Blumberg, MD, FIDSA, University of Pennsylanvia

Presentations:

10:45 AM
152

11:15 AM
153
Hepatitis Viruses
John Scott, MD

11:45 AM
154

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-136-L01-P

Disclosures:

A. Limaye, Amgen: Consultant, Consulting fee
Genentech: Consultant, Consulting fee
Vical: Consultant, Consulting fee
BioRad Laboratories: Consultant, Consulting fee

E. Blumberg, None

E. Blumberg, None

J. Scott, Vertex Pharmaceuticals: Grant Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium
Genentech: Grant Investigator and Speaker's Bureau, Educational grant and Speaker honorarium
Gilead Sciences: Scientific Advisor and Speaker's Bureau, Consulting fee and Speaker honorarium
Merck: Grant Investigator and Speaker's Bureau, Research grant and Speaker honorarium
Tibotec: Grant Investigator, Research grant
Anadys: Grant Investigator, Research grant

C. Kotton, GENENTECH: Consultant, Consulting fee
CSL BEHRING: Consultant, Consulting fee
Genzyme: Consultant, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.